Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
South Africa: 'Massive' HIV Vaccine Trial Possible Soon

The only HIV vaccine in the world that worked slightly in Thailand also seems to work on South Africans.

Published
7 hours ago
From
AllAfrica
Tenofovir gel use associated with lower HSV-2 risk in women

The risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by 46% (aIRR:0.54, 95%CI:0.30-0.97, p=0.038) among women who regularly used the vaginal gel containing tenofovir, according

Published
8 hours ago
By
Lesley Odendal
Injectable cabotegravir makes progress towards human efficacy studies: doubts about injectable rilpivirine

Researchers have determined the dose of an injectable formulation of the integrase inhibitor cabotegravir (formerly GSK744) that will be taken into efficacy trials to see if it

Published
8 hours ago
By
Gus Cairns
PrEP for a new era

It was an exciting morning for pre-exposure prophylaxis (PrEP) using daily oral TDF/FTC (brand-name Truvada).

Published
29 October 2014
From
What's Up HIV (blog)
Why Did AIDS Activists Go to Geneva to Cite U.S. HIV/AIDS Policies as a Form of Racial Discrimination?

"It is important for activists to use whatever means are at our disposal -- including public embarrassment of the U.S. -- to fight all forms of discrimination," says Kenyon Farrow, the U.S. & Global Health Policy Director with Treatment Action Group (TAG).

Published
29 October 2014
From
The Body
Research for Prevention conference opens with real hope for an HIV vaccine

“There’s only one Berlin patient still. But by this time next year he will at least be joined by 40-50 Portland monkeys.” This was vaccine researcher Louis Picker,

Published
29 October 2014
By
Gus Cairns
San Francisco to spend $300K improving access to PrEP

The Board of Supervisors approved spending $300,000 Tuesday to fund so-called navigators to help residents gain access to an HIV-prevention drug, PrEP. The funding will be used to hire people in nonprofits to help residents learn about the drug, which can reduce users' chances of being infected, and to help them use their existing benefits like Medi-Cal to cover the drug expenses.

Published
29 October 2014
From
San Francisco Examiner
Opioid Maintenance Therapy Linked to Lower Hepatitis C Rates for People Who Inject Drugs

Young drug injectors who undergo opioid agonist maintenance therapy using buprenorphine or methadone have a lower likelihood of becoming infected with hepatitis C virus (HCV) than those who continue injecting or use other types of substance use treatment, according to a study published in the October 27 edition of JAMA Internal Medicine.

Published
29 October 2014
From
HIVandhepatitis.com
Dr. Robert Grant, MD, MPH: The City of Love Could Lead the Way Toward Ending HIV Transmission

As we enter our fourth decade without a cure for HIV, public interest in ending new infections has seemed to wane. Now's not the time to stop talking about AIDS. With important new treatment and prevention tools in our arsenal, San Francisco - known as the City of Love - could be the first U.S. city to end HIV transmission.

Published
29 October 2014
From
Huffington Post
Second European PrEP study closes placebo arm early due to high effectiveness

In an extraordinary development, a second European scientific trial of pre-exposure prophylaxis (PrEP) has had its randomised phase closed early due to high effectiveness, just two weeks after the

Published
29 October 2014
By
Gus Cairns
← First12345...369Next →

Filter by country